These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7773303)
1. Lack of a genetic polymorphism in the glucuronidation of fenofibric acid. Vincent-Viry M; Cossy C; Galteau MM; Gueguen R; Magdalou J; Nicolas A; Leroy P; Siest G Pharmacogenetics; 1995 Feb; 5(1):50-2. PubMed ID: 7773303 [No Abstract] [Full Text] [Related]
2. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic? Liu HF; Vincent-Viry M; Galteau MM; Guéguen R; Magdalou J; Nicolas A; Leroy P; Siest G Eur J Clin Pharmacol; 1991; 41(2):153-9. PubMed ID: 1743248 [TBL] [Abstract][Full Text] [Related]
3. An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers. Martin PD; Dane AL; Schneck DW; Warwick MJ Clin Ther; 2003 Feb; 25(2):459-71. PubMed ID: 12749507 [TBL] [Abstract][Full Text] [Related]
4. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials. Godfrey AR; Digiacinto J; Davis MW Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241 [TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of fenofibric acid by carbonyl reducing enzymes. Malátková P; Kanavi M; Nobilis M; Wsól V Chem Biol Interact; 2016 Oct; 258():153-8. PubMed ID: 27599626 [TBL] [Abstract][Full Text] [Related]
6. Fungal mediated generation of mammalian metabolites of fenofibrate and enhanced pharmacological activity of the main metabolite fenofibric acid. Prasad GS; Govardhan P; Girisham S; Reddy SM Drug Metab Lett; 2014; 8(2):88-95. PubMed ID: 24910236 [TBL] [Abstract][Full Text] [Related]
7. Effect of hemodialysis on plasma kinetics of fenofibrate in chronic renal failure. Desager JP; Costermans J; Verberckmoes R; Harvengt C Nephron; 1982; 31(1):51-4. PubMed ID: 7110477 [TBL] [Abstract][Full Text] [Related]
8. Fenofibric Acid Can Cause False-Positive Urine Methylenedioxymethamphetamine Immunoassay Results. Quesada L; Gomila I; Fe A; Servera MA; Yates C; Morell-Garcia D; Castanyer B; Barceló B J Anal Toxicol; 2015; 39(9):734-40. PubMed ID: 26203185 [TBL] [Abstract][Full Text] [Related]
9. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes. Cornu-Chagnon MC; Dupont H; Edgar A Fundam Appl Toxicol; 1995 Jun; 26(1):63-74. PubMed ID: 7657063 [TBL] [Abstract][Full Text] [Related]
10. [High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine]. Abe S; Ono K; Mogi M; Hayashi T Yakugaku Zasshi; 1998 Oct; 118(10):447-55. PubMed ID: 9800517 [TBL] [Abstract][Full Text] [Related]
11. In vitro glucuronidation of fenofibric acid by human UDP-glucuronosyltransferases and liver microsomes. Tojcic J; Benoit-Biancamano MO; Court MH; Straka RJ; Caron P; Guillemette C Drug Metab Dispos; 2009 Nov; 37(11):2236-43. PubMed ID: 19661212 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid. Goosen TC; Bauman JN; Davis JA; Yu C; Hurst SI; Williams JA; Loi CM Drug Metab Dispos; 2007 Aug; 35(8):1315-24. PubMed ID: 17470524 [TBL] [Abstract][Full Text] [Related]
13. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer. Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922 [TBL] [Abstract][Full Text] [Related]
14. Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry. Wei X; Li P; Liu M; Du Y; Wang M; Zhang J; Wang J; Liu H; Liu X Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27594083 [TBL] [Abstract][Full Text] [Related]
15. Distribution of fenofibric acid in lipoprotein fractions of patients. Nobilis M; Kvetina J; Anzenbacher P; Vontor T; Svoboda D; Brátová M; Solichová D; Zadák Z; Bláha V; Vlcek J Eur J Drug Metab Pharmacokinet; 1998; 23(2):287-94. PubMed ID: 9725495 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies. Prasad GS; Govardhan P; Deepika G; Vakdevi V; Sashidhar RB Inflammopharmacology; 2018 Aug; 26(4):973-981. PubMed ID: 29238904 [TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia. Raslová K; Dubovská D; Mongiellová V; Trnovec T Eur J Clin Pharmacol; 1997; 52(2):101-6. PubMed ID: 9174678 [TBL] [Abstract][Full Text] [Related]
18. Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs. Kim KS; Jin SG; Mustapha O; Yousaf AM; Kim DW; Kim YH; Kim JO; Yong CS; Woo JS; Choi HG Int J Pharm; 2015 Jul; 490(1-2):273-80. PubMed ID: 26024820 [TBL] [Abstract][Full Text] [Related]
20. Determination of Fenofibric Acid in Rat Plasma and its Application to a Comparative Pharmacokinetic Study of JW322 and Fenofibrate. Kim TK Drug Res (Stuttg); 2017 Sep; 67(9):534-538. PubMed ID: 28561239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]